Skip to main content

Advertisement

Properties of Zinc Oxide Nanoparticles and Their Activity Against Microbes

Article metrics

Abstract

Zinc oxide is an essential ingredient of many enzymes, sun screens, and ointments for pain and itch relief. Its microcrystals are very efficient light absorbers in the UVA and UVB region of spectra due to wide bandgap. Impact of zinc oxide on biological functions depends on its morphology, particle size, exposure time, concentration, pH, and biocompatibility. They are more effective against microorganisms such as Bacillus subtilis, Bacillus megaterium, Staphylococcus aureus, Sarcina lutea, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumonia, Pseudomonas vulgaris, Candida albicans, and Aspergillus niger. Mechanism of action has been ascribed to the activation of zinc oxide nanoparticles by light, which penetrate the bacterial cell wall via diffusion. It has been confirmed from SEM and TEM images of the bacterial cells that zinc oxide nanoparticles disintegrate the cell membrane and accumulate in the cytoplasm where they interact with biomolecules causing cell apoptosis leading to cell death.

Background

Nanotechnology deals with the manufacture and application of materials with size of up to 100 nm. They are widely used in a number of processes that include material science, agriculture, food industry, cosmetic, medical, and diagnostic applications [1,2,3,4,5,6,7,8,9,10]. Nanosize inorganic compounds have shown remarkable antibacterial activity at very low concentration due to their high surface area to volume ratio and unique chemical and physical features [11]. In addition, these particles are also more stable at high temperature and pressure [12]. Some of them are recognized as nontoxic and even contain mineral elements which are vital for human body [13]. It has been reported that the most antibacterial inorganic materials are metallic nanoparticles and metal oxide nanoparticles such as silver, gold, copper, titanium oxide, and zinc oxide [14, 15].

Zinc is an essential trace element for human system without which many enzymes such as carbonic anhydrase, carboxypeptidase, and alcohol dehydrogenase become inactive, while the other two members, cadmium and mercury belonging to the same group of elements having the same electronic configuration, are toxic. It is essential for eukaryotes because it modulates many physiological functions [16, 17]. Bamboo salt, containing zinc, is used as herbal medicine for the treatment of inflammation by regulating caspase-1 activity. Zinc oxide nanoparticles have been shown to reduce mRNA expression of inflammatory cytokines by inhibiting the activation of NF-kB (nuclear factor kappa B cells) [18].

Globally, bacterial infections are recognized as serious health issue. New bacterial mutation, antibiotic resistance, outbreaks of pathogenic strains, etc. are increasing, and thus, development of more efficient antibacterial agents is demand of the time. Zinc oxide is known for its antibacterial properties from the time immemorial [19]. It had been in use during the regime of Pharaohs, and historical records show that zinc oxide was used in many ointments for the treatment of injuries and boils even in 2000 BC [20]. It is still used in sun screen lotion, as a supplement, photoconductive material, LED, transparent transistors, solar cells, memory devices [21, 22], cosmetics [23, 24], and catalysis [25]. Although considerable amount of ZnO is produced every year, very small quantity is used as medicine [26]. The US Food and Drug Administration has recognized (21 CFR 182.8991) zinc oxide as safe [27]. It is characterized by photocatalytic and photooxidizing properties against biochemicals [28].

Zinc oxide has been classified by EU hazard classification as N; R50-53 (ecotoxic). Compounds of zinc are ecotoxic for mammals and plants in traces [29, 30]. Human body contains about 2–3 g of zinc, and the daily requirement is 10–15 mg [29, 31]. No report has demonstrated carcinogenicity, genotoxicity, and reproduction toxicity in humans [29, 32]. However, zinc powder inhaled or ingested may produce a condition called zinc fever, which is followed by chill, fever, cough, etc.

Morphology of zinc oxide nanoparticles depends on the process of synthesis. They may be nanorods, nanoplates [33,34,35], nanospheres [36], nanoboxes [35], hexagonal, tripods [37], tetrapods [38], nanowires, nanotubes, nanorings [39,40,41], nanocages, and nanoflowers [42, 43]. Zinc oxide nanoparticles are more active against gram-positive bacteria relative to other NPs of the same group of elements. Ready to eat food is more prone to infection by Salmonella, Staphylococcus aureus, and E. coli which pose a great challenge to food safety and quality. The antimicrobial compounds are incorporated in the packed food to prevent them from damage. Antimicrobial packaging contains a nontoxic material which inhibits or slows down the growth of microbes present in food or packaging material [44]. An antimicrobial substance for human consumption must possess the following properties.

  1. a)

    It should be nontoxic.

  2. b)

    It should not react with food or container.

  3. c)

    It should be of good taste or tasteless.

  4. d)

    It should not have disagreeable smell.

Zinc oxide nanoparticle is one such inorganic metal oxide which fulfills all the above requirements, and hence, it can safely be used as medicine, preservative in packaging, and an antimicrobial agent [45, 46]. It easily diffuses into the food material, kill the microbes, and prevent human being from falling ill. In accordance with the regulations 1935/2004/EC and 450/2009/EC of the European Union, active packaging is defined as active material in contact with food with ability to change the composition of the food or the atmosphere around it [47]. Therefore, it is commonly used as preservative and incorporated in polymeric packaging material to prevent food material from damage by microbes [48]. Zinc oxide nanoparticles have been used as an antibacterial substance against Salmonella typhi and S. aureus in vitro. Of all the metal oxide nanoparticles studied thus far, zinc oxide nanoparticles exhibited the highest toxicity against microorganisms [49]. It has also been demonstrated from SEM and TEM images that zinc oxide nanoparticles first damage the bacterial cell wall, then penetrate, and finally accumulate in the cell membrane. They interfere with metabolic functions of the microbes causing their death. All the characteristics of the zinc oxide nanoparticles depend on their particle size, shape, concentration, and exposure time to the bacterial cell. Further, biodistribution studies of zinc oxide nanoparticles have also been examined. For instance, Wang et al. [50] have investigated the effect of long-term exposure of zinc oxide nanoparticle on biodistribution and zinc metabolism in mice over 3 to 35 weeks. Their results showed minimum toxicity to mice when they were exposed to 50 and 500 mg/kg zinc oxide nanoparticle in diet. At higher dose of 5000 mg/kg, zinc oxide nanoparticle decreased body weight but increased the weight of the pancreas, brain, and lung. Also, it increased the serum glutamic-pyruvic transaminase activity and mRNA expression of zinc metabolism-related genes such as metallothionein. Biodistribution studies showed the accumulation of sufficient quantity of zinc in the liver, pancreas, kidney, and bones. Absorption and distribution of zinc oxide nanoparticle/zinc oxide microparticles are largely dependent on the particle size. Li et al. [51] have studied biodistribution of zinc oxide nanoparticles fed orally or through intraperitoneal injection to 6 weeks old mice. No obvious adverse effect was detected in zinc oxide nanoparticles orally treated mice in 14 days study. However, intraperitoneal injection of 2.5 g/kg body weight given to mice showed accumulation of zinc in the heart, liver, spleen, lung, kidney, and testes. Nearly ninefold increase in zinc oxide nanoparticle in the liver was observed after 72 h. Zinc oxide nanoparticles have been shown to have better efficiency in liver, spleen, and kidney biodistribution than in orally fed mice. Since zinc oxide nanoparticles are innocuous in low concentrations, they stimulate certain enzymes in man and plants and suppress diseases. Singh et al. [52] have also been recently reviewed the biosynthesis of zinc oxide nanoparticle, their uptake, translocation, and biotransformation in plant system.

In this review, we have attempted to consolidate all the information regarding zinc oxide nanoparticles as antibacterial agent. The mechanism of interaction of zinc oxide nanoparticles against a variety of microbes has also been discussed in detail.

Antimicrobial Activity of Zinc Oxide Nanoparticles

It is universally known that zinc oxide nanoparticles are antibacterial and inhibit the growth of microorganisms by permeating into the cell membrane. The oxidative stress damages lipids, carbohydrates, proteins, and DNA [53]. Lipid peroxidation is obviously the most crucial that leads to alteration in cell membrane which eventually disrupt vital cellular functions [54]. It has been supported by oxidative stress mechanism involving zinc oxide nanoparticle in Escherichia coli [55]. However, for bulk zinc oxide suspension, external generation of H2O2 has been suggested to describe the anti-bacterial properties [56]. Also, the toxicity of nanoparticles, releasing toxic ions, has been considered. Since zinc oxide is amphoteric in nature, it reacts with both acids and alkalis giving Zn2+ ions.

figurea

The free Zn2+ ions immediately bind with the biomolecules such as proteins and carbohydrates, and all vital functions of bacteria cease to continue. The toxicity of zinc oxide, zinc nanoparticles, and ZnSO4·7H2O has been tested (Table 1) against Vibrio fischeri. It was found that ZnSO4·7H2O is six times more toxic than zinc oxide nanoparticles and zinc oxide. The nanoparticles are actually dispersed in the solvent, not dissolved, and therefore, they cannot release Zn2+ ions. The bioavailability of Zn2+ ions is not always 100% and may invariably change with physiological pH, redox potential, and the anions associated with it such as Cl or SO42−.

Table 1 The toxicity (30-min EC50, EC20 and NOEC, and MIC) of metal oxide aqueous suspensions CuSO4 and ZnSO4·7H2O to bacteria Vibrio fischeri [59]

Solubility of zinc oxide (1.6–5.0 mg/L) in aqueous medium is higher than that of zinc oxide nanoparticles (0.3–3.6 mg/L) in the same medium [57] which is toxic to algae and crustaceans. Both nano-zinc oxide and bulk zinc oxide are 40–80-fold less toxic than ZnSO4 against V. fischeri. The higher antibacterial activity of ZnSO4 is directly proportional to its solubility releasing Zn2+ ions, which has higher mobility and greater affinity [58] toward biomolecules in the bacterial cell due to positive charge on the Zn2+ and negative charge on the biomolecules.

figureb

Since zinc oxide and its nanoparticles have limited solubility, they are less toxic to the microbes than highly soluble ZnSO4·7H2O. However, it is not essential for metal oxide nanoparticles to enter the bacterial cell to cause toxicity [59]. Contact between nanoparticles and the cell wall is sufficient to cause toxicity. If it is correct, then large amounts of metal nanoparticles are required so that the bacterial cells are completely enveloped and shielded from its environment leaving no chance for nutrition to be absorbed to continue life process. Since nanoparticles and metal ions are smaller than the bacterial cells, it is more likely that they disrupt the cell membrane and inhibit their growth.

A number of nanosized metal oxides such as ZnO, CuO, Al2O3, La2O3, Fe2O3, SnO2, and TiO2 have been shown to exhibit the highest toxicity against E. coli [49]. Zinc oxide nanoparticles are externally used for the treatment of mild bacterial infections, but the zinc ion is an essential trace element for some viruses and human beings which increase enzymatic activity of viral integrase [45, 60, 61]. It has also been supported by an increase in the infectious pancreatic necrosis virus by 69.6% when treated with 10 mg/L of Zn [46]. It may be due to greater solubility of Zn ions relative to ZnO alone. The SEM and TEM images have shown that zinc oxide nanoparticles damage the bacterial cell wall [55, 62] and increase permeability followed by their accumulation in E. coli preventing their multiplication [63].

In the recent past, antibacterial activity of zinc oxide nanoparticle has been investigated against four known gram-positive and gram-negative bacteria, namely Staphylococcus aureus, E. coli, Salmonella typhimurium, and Klebsiella pneumoniae. It was observed that the growth-inhibiting dose of the zinc oxide nanoparticles was 15 μg/ml, although in the case of K. pneumoniae, it was as low as 5 μg/ml [63, 64]. It has been noticed that with increasing concentration of nanoparticles, growth inhibition of microbes increases. When they were incubated over a period of 4–5 h with a maximum concentration of zinc oxide nanoparticles of 45 μg/ml, the growth was strongly inhibited. It is expected that if the incubation time is increased, the growth inhibition would also increase without much alteration in the mechanism of action [63].

It has been reported that the metal oxide nanoparticles first damage the bacterial cell membrane and then permeate into it [64]. It has also been proposed that the release of H2O2 may be an alternative to anti-bacterial activity [65]. This proposal, however, requires experimental proof because the mere presence of zinc oxide nanoparticle is not enough to produce H2O2. Zinc nanoparticles or zinc oxide nanoparticles of extremely low concentration cannot cause toxicity in human system. Daily intake of zinc via food is needed to carry out the regular metabolic functions. Zinc oxide is known to protect the stomach and intestinal tract from damage by E. coli [65]. The pH in the stomach varies between 2 to 5, and hence, zinc oxide in the stomach can react with acid to produce Zn2+ ions. They can help in activating the enzyme carboxy peptidase, carbonic anhydrase, and alcohol dehydrogenase which help in the digestion of carbohydrate and alcohol. Premanathan et al. [66] have reported the toxicity of zinc oxide nanoparticles against prokaryotic and eukaryotic cells. The MIC of zinc oxide nanoparticles against E. coli, Pseudomonas aeruginosa, and S. aureus were found to be 500 and 125 μg/ml, respectively. Two mechanisms of action have been proposed for the toxicity of zinc oxide nanoparticles, namely (1) generation of ROS and (2) induction of apoptosis. Metal oxide nanoparticles induce ROS production and put the cells under oxidative stress causing damage to cellular components, i.e., lipids, proteins, and DNA [67,68,69]. Zinc oxide nanoparticles, therefore, induce toxicity through apoptosis. They are relatively more toxic to cancer cells than normal cells, although they cannot distinguish between them.

Recently, Pati et al. [70] have shown that zinc oxide nanoparticles disrupt bacterial cell membrane integrity, reduce cell surface hydrophobicity, and downregulate the transcription of oxidative stress-resistance genes in bacteria. They enhance intracellular bacterial killing by inducing ROS production. These nanoparticles disrupt biofilm formation and inhibit hemolysis by hemolysin toxin produced by pathogens. Intradermal administration of zinc oxide nanoparticles was found to significantly reduce the skin infection and inflammation in mice and also improved infected skin architecture.

Solubility and Concentration-Dependent Activity of Zinc Oxide Nanoparticle

Nanoparticles have also been used as a carrier to deliver therapeutic agents to treat bacterial infection [1, 9]. Since zinc oxide nanoparticles up to a concentration of 100 μg/ml are harmless to normal body cells, they can be used as an alternative to antibiotics. It was found that 90% bacterial colonies perished after exposing them to a dose of 500–1000 μg/ml of zinc oxide nanoparticles only for 6 h. Even the drug-resistant S. aureus, Mycobacterium smegmatis, and Mycobacterium bovis when treated with zinc oxide nanoparticles in combination with a low dose of anti-tuberculosis drug, rifampicin (0.7 μg/ml), a significant reduction in their growth was observed. These pathogens were completely destroyed when incubated for 24 h with 1000 μg/ml of zinc oxide nanoparticles. It is, therefore, concluded that if the same dose is repeated, the patient with such infective diseases may be completely cured. It was also noted that the size of zinc oxide nanoparticles ranging between 50 and 500 nm have identical effect on bacterial growth inhibition.

Cytotoxicity of zinc oxide has been studied by many researchers in a variety of microbes and plant systems [71,72,73,74]. Toxicity of zinc oxide nanoparticles is concentration and solubility dependent. It has been shown that maximum exposure concentration of zinc oxide (125 mg/l) suspension released 6.8 mg/l of Zn2+ ions. Toxicity is a combined effect of zinc oxide nanoparticles and Zn2+ ions released in the aqueous medium. However, minimal effect of metal ions was detected which suggests that the bacterial growth inhibition is mainly due to interaction of zinc oxide nanoparticles with microorganisms. The cytotoxic effect of a particular metal oxide nanoparticle is species sensitive which is reflected by the growth inhibition zone for several bacteria [75].

It has been suggested that growth inhibition of bacterial cells occurs mainly by Zn2+ ions which are produced by extracellular dissolution of zinc oxide nanoparticles [76]. Cho et al. [77] have concluded from their studies on rats that zinc oxide nanoparticles remain intact at around neutral or biological pH but rapidly dissolve under acidic conditions (pH 4.5) in the lysosome of the microbes leading to their death. This is true because in acidic condition, zinc oxide dissolves and Zn2+ ions are produced, which bind to the biomolecules inside the bacterial cell inhibiting their growth.

figurec

The zinc oxide nanoparticles have been shown to be cytotoxic to different primary immune-competent cells. The transcriptomics analysis showed that nanoparticles had a common gene signature with upregulation of metallothionein genes ascribed to the dissolution of the nanoparticles [78]. However, it could not be ascertained if the absorbed zinc was Zn2+ or zinc oxide or both, although smaller sized zinc oxide nanoparticles have greater concentration in the blood than larger ones (19 and > 100 nm). The efficiency of zinc oxide nanoparticles depends mainly on the medium of reaction to form Zn2+ and their penetration into the cell.

Chiang et al. [79] have reported that dissociation of zinc oxide nanoparticles results in destruction of cellular Zn homeostasis. The characteristic properties of nanoparticles and their impact on biological functions are entirely different from those of the bulk material [80]. Aggregation of nanoparticles influences cytotoxicity of macrophages, and their concentration helps in modulation of nanoparticle aggregation. Low concentration of zinc oxide nanoparticles is ineffective, but at higher concentration (100 μg/ml), they exhibited cytotoxicity which varies from one pathogen to another.

The inadvertent use of zinc oxide nanoparticles may sometime adversely affect the living system. Their apoptosis and genotoxic potential in human liver cells and cellular toxicity has been studied. It was found that a decrease in liver cell viability occurs when they are exposed to 14–20 μg/ml of zinc oxide nanoparticles for 12 h. It also induced DNA damage by oxidative stress. Sawai et al. [56] have demonstrated that ROS generation is directly proportional to the concentration of zinc oxide powder. ROS triggered a decrease in mitochondria membrane potential leading to apoptosis [81]. Cellular uptake of nanoparticles is not mandatory for cytotoxicity to occur.

Size-Dependent Antibacterial Activity of Zinc Oxide Nanoparticles

In a study, Azam et al. [82] have reported that the antimicrobial activity against both gram-negative (E. coli and P. aeruginosa) and gram-positive (S. and Bacillus subtilis) bacteria increased with increase in surface-to-volume ratio due to a decrease in particle size of zinc oxide nanoparticles. Moreover, in this investigation, zinc oxide nanoparticles have shown maximum (25 mm) bacterial growth inhibition against B. subtilis (Fig. 1).

Fig. 1
figure1

Antibacterial activity and/or zone of inhibition produced by zinc oxide nanoparticles against gram-positive and gram-negative bacterial strains namely a Escherichia coli, b Staphylococcus aureus, c Pseudomonas aeruginosa, and d Bacillus subtilis [82]

It has been reported that the smaller size of zinc oxide nanoparticles exhibits greater antibacterial activity than microscale particles [83]. For instance, Au55 nanoparticles of 1.4-nm size have been demonstrated to interact with the major grooves of DNA which accounts for its toxicity [84]. Although contradictory results have been reported, many workers showed positive effect of zinc oxide nanoparticles on bacterial cells. However, Brayner et al. [63] from TEM images have shown that zinc oxide nanoparticle of 10–14 nm were internalized (when exposed to microbes) and damaged the bacterial cell membrane. It is also essential that the zinc/zinc oxide nanoparticles must not be toxic to human being since they are toxic to T cells above 5 mM [85] and to neuroblastoma cells above 1.2 mM [86]. Nair et al. [87] have exclusively explored the size effect of zinc oxide nanoparticles on bacterial and human cell toxicity. They have studied the influence of zinc oxide nanoparticles on both gram-positive and gram-negative bacteria and osteoblast cancer cell lines (MG-63).

It is known that antibacterial activity of zinc oxide nanoparticle is inversely proportional to their size and directly proportional to their concentration [88]. It has also been noticed that it does not require UV light for activation; it functions under normal or even diffused sunlight. Cytotoxic activity perhaps involves both the production of ROS and accumulation of nanoparticles in the cytoplasm or on the outer cell membrane. However, the production of H2O2 and its involvement in the activation of nanoparticles cannot be ignored. Raghupathi et al. [88] have synthesized zinc oxide nanoparticles from different zinc salts and observed that nanoparticles obtained from Zn(NO3)2 were smallest in size (12 nm) and largest in surface area (90.4). Authors have shown that the growth inhibition of S. aureus at a concentration of 6 mM of zinc oxide nanoparticles is size dependent. It has also been indicated from the viable cell determination during the exposure of bacterial cells to zinc oxide nanoparticles that the number of cells recovered decreased significantly with decrease in size of zinc oxide nanoparticles. Jones et al. [89] have shown that zinc oxide nanoparticles of 8-nm diameter inhibited the growth of S. aureus, E. coli, and B. subtilis. Zinc oxide nanoparticles ranging between 12 and 307 nm were selected and confirmed the relationship between antibacterial activity and their size. Their toxicity to microbes has been ascribed to the formation of Zn2+ ions from zinc oxide when it is suspended in water and also to some extent to a slight change in pH. Since Zn2+ ions are scarcely released from zinc oxide nanoparticles, the antibacterial activity is mainly owing to smaller zinc oxide nanoparticles. When the size is 12 nm, it inhibits the growth of S. aureus, but when the size exceeds 100 nm, the inhibitory effect is minimal [89].

Shape, Composition, and Cytotoxicity of Zinc Oxide Nanoparticles

Zinc oxide nanoparticles have shown cytotoxicity in concentration-dependent manner and type of cells exposed due to different sensitivity [90, 91]. Sahu et al. [90] have highlighted the difference of cytotoxicity between particle size and different sensitivity of cells toward the particles of the same composition. In another recent study, Ng et al. [91] examined the concentration-dependent cytotoxicity in human lung MRC5 cells. Authors have reported the uptake and internalization of zinc oxide nanoparticles into the human lung MRC5 cells by using TEM investigation. These particles were noticed in the cytoplasm of the cells in the form of electron dense clusters, which are further observed to be enclosed by vesicles, while zinc oxide nanoparticles were not found in untreated control cells. Papavlassopoulos et al. [92] have synthesized zinc oxide nanoparticle tetrapods by entirely a novel route known as “Flame transport synthesis approach”. Tetrapods have different morphology compared to the conventionally synthesized zinc oxide nanoparticles. Their interaction with mammalian fibroblast cells in vitro has indicated that their toxicity is significantly lower than those of the spherical zinc oxide nanoparticles. Tetrapods exhibited hexagonal wurtzite crystal structure with alternating Zn2+ and O2− ions with three-dimensional geometry. They block the entry of viruses into living cells which is further enhanced by precisely illuminating them with UV radiation. Since zinc oxide tetrapods have oxygen vacancies in their structure, the Herpes simplex viruses are attached via heparan sulfate and denied entry into body cells. Thus, they prevent HSV-1 and HSV-2 infection in vitro. Zinc oxide tetrapods may therefore be used as prophylactic agent against these viral infections. The cytotoxicity of zinc oxide nanoparticles also depends on the proliferation rate of mammalian cells [66, 93]. The surface reactivity and toxicity may also be varied by controlling the oxygen vacancy in zinc oxide tetrapods. When they are exposed to UV light, the oxygen vacancy in tetrapods is readily increased. Alternatively, the oxygen vacancy can be decreased by heating them in oxygen-rich environment. Thus, it is the unique property of zinc oxide tetrapods that can be changed at will which consequently alter their antimicrobial efficiency.

Animal studies have indicated an increase in pulmonary inflammation, oxidative stress, etc. on respiratory exposure to nanoparticles [94]. Yang et al. [95] have investigated the cytotoxicity, genotoxicity, and oxidative stress of zinc oxide nanoparticles on primary mouse embryo fibroblast cells. It was observed that zinc oxide nanoparticles induced significantly greater cytotoxicity than that induced by carbon and SiO2 nanoparticles. It was further confirmed by measuring glutathione depletion, malondialdehyde production, superoxide dismutase inhibition, and ROS generation. The potential cytotoxic effects of different nanoparticles have been attributed to their shape.

Polymer-Coated Nanoparticles

Many bacterial infections are transmitted by contact with door knobs, key boards, water taps, bath tubs, and telephones; therefore, it is essential to develop and coat such surfaces with inexpensive advanced antibacterial substances so that their growth is inhibited. It is important to use such concentrations of antibacterial substances that they may kill the pathogens but spare the human beings. It may happen only if they are coated with a biocompatible hydrophilic polymer of low cost. Schwartz et al. [96] have reported the preparation of a novel antimicrobial composite material hydrogel by mixing a biocompatible poly (N-isopropylacrylamide) with zinc oxide nanoparticles. The SEM image of the composite film showed uniform distribution of zinc oxide nanoparticles. It exhibited antibacterial activity against E. coli at a very low zinc oxide concentration (1.33 mM). Also, the coating was found to be nontoxic toward mammalian cell line (N1H/3T3) for a period of 1 week. Zinc oxide/hydrogel nanocomposite may safely be used as biomedical coating to prevent people from contracting bacterial infections.

Although zinc oxide nanoparticles are stable, they have been further stabilized by coating them with different polymers such as polyvinyl pyrolidone (PVP), polyvinyl alcohol (PVA), poly (α, γ, l-glutamic acid) (PGA), polyethylene glycol (PEG), chitosan, and dextran [97, 98]. The antibacterial activity of engineered zinc oxide nanoparticles was examined against gram-negative and gram-positive pathogens, namely E. coli and S. aureus and compared with commercial zinc oxide powder. The polymer-coated spherical zinc oxide nanoparticles showed maximum bacterial cell destruction compared to bulk zinc oxide powder [99]. Since nanoparticles coated with polymers are less toxic due to their low solubility and sustained release, their cytotoxicity can be controlled by coating them with a suitable polymer.

Effect of Particle Size and Shape of Polymer-Coated Nanoparticles on Antibacterial Activity

E. coli and S. aureus exposed to different concentrations of poly ethylene glycol (PEG)-coated zinc oxide nanoparticles (1–7 mM) of varying size (401 nm–1.2 μm) showed that the antimicrobial activity increases with decreasing size and increasing concentration of nanoparticles. However, the effective concentration in all these cases was above 5 mM. There occurs a drastic change in cell morphology of E. coli surface which can be seen from the SEM images of bacteria before and after their exposure to zinc oxide nanoparticles [84]. It has been nicely demonstrated by Nair et al. [87] that PEG-capped zinc oxide particles and zinc oxide nanorods are toxic to human osteoblast cancer cells (MG-63) at concentration above 100 μM. The PEG starch-coated nanorods/nanoparticles do not damage the healthy cells.

In Vivo and In Vitro Antimicrobial Activity for Wound Dressing

Of all natural and synthetic wound dressing materials, the chitosan hydrogel microporous bandages laced with zinc oxide nanoparticles developed by Kumar et al. [100] are highly effective in treating burns, wounds, and diabetic foot ulcers. The nanoparticles of approximately 70–120 nm are dispersed on the surface of the bandage. The degradation products of chitosan were identified as d-glucosamine and glycosamine glycan. They are nontoxic to the cells because they are already present in our body for the healing of injury. The wound generally contains P. aeruginosa, S. intermedicus, and S. hyicus which were also identified from the swab of mice wound and successfully treated with chitosan zinc oxide bandage in about 3 weeks [100].

Effect of Doping on Toxicity of Zinc Oxide Nanoparticles

Doping of zinc oxide nanoparticles with iron reduces the toxicity. The concentration of Zn2+ and zinc oxide nanoparticles is also an important factor for toxicity. The concentration that reduced 50% viability in microbial cells exposed to nano- and microsize zinc oxide is very close to the concentration of Zn2+ that induced 50% reduction in viability in Zn2+-treated cells [101, 102].

Coating of zinc oxide nanoparticles with mercaptopropyl trimethoxysilane or SiO2 reduces their cytotoxicity [103]. On the contrary, Gilbert et al. [104] showed that in BEAS-2B cells, uptake of zinc oxide nanoparticles is the main mechanism of zinc accumulation. Also, they have suggested that zinc oxide nanoparticles dissolve completely generating Zn2+ ions which are bonded to biomolecules of the target cells. However, the toxicity of zinc oxide nanoparticles depends on the uptake and their subsequent interaction with target cells.

Interaction Mechanism of Zinc Oxide Nanoparticles

Nanoparticles may be toxic to some microorganisms, but they may be essential nutrients to some of them [55, 105]. Nanotoxicity is essentially related to the microbial cell membrane damage leading to the entry of nanoparticles into the cytoplasm and their accumulation [55]. The impact of nanoparticles on the growth of bacteria and viruses largely depends on particle size, shape, concentration, agglomeration, colloidal formulation, and pH of the media [106,107,108]. The mechanism of antimicrobial activity of zinc oxide nanoparticles has been depicted in Fig. 2.

Fig. 2
figure2

Mechanisms of zinc oxide nanoparticle antimicrobial activity

Zinc oxide nanoparticles are generally less toxic than silver nanoparticles in a broad range of concentrations (20 to 100 mg/l) with average particle size of 480 nm [55, 62, 63]. Metal oxide nanoparticles damage the cell membrane and DNA [63, 109,110,111] of microbes via diffusion. However, the production of ROS through photocatalysis causing bacterial cell death cannot be ignored [112]. UV-Vis spectrum of zinc oxide nanoparticle suspension in aqueous medium exhibits peaks between 370 and 385 nm [113]. It has been shown that it produces ROS (hydroxyl radicals, superoxides, and hydrogen peroxide) in the presence of moisture which ostensibly react with bacterial cell material such as protein, lipids, and DNA, eventually causing apoptosis. Xie et al. [114] have examined the influence of zinc oxide nanoparticles on Campylobacter jejuni cell morphology using SEM images (Fig. 3). After a 12-h treatment (0.5 mg/ml), C. jejuni was found to be extremely sensitive and cells transformed from spiral shape to coccoid forms. SEM studies showed the ascendency of coccoid forms in the treated cells and display the formation of irregular cell surfaces and cell wall blebs (Fig. 3a). Moreover, these coccoid cells remained intact and possessed sheathed polar flagella. However, SEM image of the untreated cells clearly showed spiral shapes (Fig. 3b). In general, it has been demonstrated from SEM and TEM images of bacterial cells treated with zinc oxide nanoparticles that they get ruptured and, in many cases, the nanoparticles damage the cell wall forcing their entry into it [114, 115].

Fig. 3
figure3

SEM images of Campylobacter jejuni. a Untreated cells from the same growth conditions were used as a control. b C. jejuni cells in the mid-log phase of growth were treated with 0.5 mg/ml of zinc oxide nanoparticles for 12 h under microaerobic conditions [114]

Zinc oxide nanoparticles have high impact on the cell surface and may be activated when exposed to UV-Vis light to generate ROS (H2O2) which permeate into the cell body while the negatively charged ROS species such as O22− remain on the cell surface and affect their integrity [116, 117]. Anti-bacterial activity of zinc oxide nanoparticles against many other bacteria has also been reported [1, 5, 114, 115]. It has been shown from TEM images that the nanoparticles have high impact on the cell surface (Fig. 4).

Fig. 4
figure4

a TEM images of untreated normal Salmonella typhimurium cells. b Effects of nanoparticles on the cells (marked with arrows). c, d Micrograph of deteriorated and ruptured S. typhimurium cells treated with zinc oxide nanoparticles [115]

Sinha et al. [118] have also shown the influence of zinc oxide nanoparticles and silver nanoparticles on the growth, membrane structure, and their accumulation in cytoplasm of (a) mesophiles: Enterobacter sp. (gram negative) and B. subtilis (gram positive) and (b) halophiles: halophilic bacterium sp. (gram positive) and Marinobacter sp. (gram negative). Nanotoxicity of zinc oxide nanoparticles against halophilic gram-negative Marinobacter species and gram-positive halophilic bacterial species showed 80% growth inhibition. It was demonstrated that zinc oxide nanoparticles below 5 mM concentration are ineffective against bacteria. The bulk zinc oxide also did not affect the growth rate and viable counts, although they showed substantial decrease in these parameters. Enterobacter species showed dramatic alterations in cell morphology and reduction in size when treated with zinc oxide.

TEM images shown by Akbar and Anal [115] revealed the disrupted cell membrane and accumulation of zinc oxide nanoparticles in the cytoplasm (Fig. 4) which was further confirmed by FTIR, XRD, and SEM. It has been suggested that Zn2+ ions are attached to the biomolecules in the bacterial cell via electrostatic forces. They are actually coordinated with the protein molecules through the lone pair of electrons on the nitrogen atom of protein part. Although there is significant impact of zinc oxide nanoparticles on both the aquatic and terrestrial microorganisms and human system, it is yet to be established whether it is due to nanoparticles alone or is a combined effect of the zinc oxide nanoparticles and Zn2+ ions [55, 106, 109, 119]. Antibacterial influence of metal oxide nanoparticles includes its diffusion into the bacterial cell, followed by release of metal ions and DNA damage leading to cell death [63, 109,110,111]. The generation of ROS through photocatalysis is also a reason of antibacterial activity [62, 112]. Wahab et al. [120] have shown that when zinc oxide nanoparticles are ingested, their surface area is increased followed by increased absorption and interaction with both the pathogens and the enzymes. Zinc oxide nanoparticles can therefore be used in preventing the biological system from infections. It is clear from TEM images (Fig. 5a, b) of E. coli incubated for 18 h with MIC of zinc oxide nanoparticles that they had adhered to the bacterial cell wall. The outer cell membrane was ruptured leading to cell lysis. In some cases, the cell cleavage of the microbes has not been noticed, but the zinc oxide nanoparticles can yet be seen entering the inner cell wall (Fig. 5c, d). As a consequence of it, the intracellular material leaks out leading to cell death, regardless of the thickness of bacterial cell wall.

Fig. 5
figure5

TEM images of Escherichia coli (a), zinc oxide nanoparticles with E. coli at different stages (b and inset), Klebsiella pneumoniae (c), and zinc oxide nanoparticles with K. pneumoniae (d and inset) [120]

Mechanism of interaction of zinc oxide nanoparticles with bacterial cells has been outlined below [120]. Zinc oxide absorbs UV-Vis light from the sun and splits the elements of water.

figured

Dissolved oxygen molecules are transformed into superoxide, O2, which in turn reacts with H+ to generate HO2 radical and after collision with electrons produces hydrogen peroxide anion, HO2. They subsequently react with H+ ions to produce H2O2.

figuree

It has been suggested that negatively charged hydroxyl radicals and superoxide ions cannot penetrate into the cell membrane. The free radicals are so reactive that they cannot stay in free and, therefore, they can either form a molecule or react with a counter ion to give another molecule. However, it is true that zinc oxide can absorb sun light and help in cleaving water molecules which may combine in many ways to give oxygen. Mechanism of oxygen production in the presence of zinc oxide nanoparticles still needs experimental evidence.

figuref

Zinc oxide at a dose of 5 μg/ml has been found to be highly effective for all the microorganisms which can be taken as minimum inhibitory dose.

Conclusions

Zinc is an indispensable inorganic element universally used in medicine, biology, and industry. Its daily intake in an adult is 8–15 mg/day, of which approximately 5–6 mg/day is lost through urine and sweat. Also, it is an essential constituent of bones, teeth, enzymes, and many functional proteins. Zinc metal is an essential trace element for man, animal, plant, and bacterial growth while zinc oxide nanoparticles are toxic to many fungi, viruses, and bacteria. People with inherent genetic deficiency of soluble zinc-binding protein suffer from acrodermatitis enteropathica, a genetic disease indicated by python like rough and scaly skin. Although conflicting reports have been received about nanoparticles due to their inadvertent use and disposal, some metal oxide nanoparticles are useful to men, animals, and plants. The essential nutrients become harmful when they are taken in excess. Mutagenic potential of zinc oxide has not been thoroughly studied in bacteria even though DNA-damaging potential has been reported. It is true that zinc oxide nanoparticles are activated by absorption of UV light without disturbing the other rays. If zinc oxide nanoparticles produce ROS, they can damage the skin and cannot be used as sun screen. Antibacterial activity may be catalyzed by sunlight, but hopefully, it can prevent the formation of ROS. Zinc oxide nanoparticles and zinc nanoparticles coated with soluble polymeric material may be used for treating wounds, ulcers, and many microbial infections besides being used as drug carrier in cancer therapy. It has great potential as a safe antibacterial drug which may replace antibiotics in future. Application of zinc oxide nanoparticles in different areas of science, medicine, and technology suggests that it is an indispensable substance which is equally important to man and animals. However, longtime exposure with higher concentration may be harmful to living system.

References

  1. 1.

    Husen A, Siddiqi KS (2014) Phytosynthesis of nanoparticles: concept, controversy and application. Nano Res Lett 9:229

  2. 2.

    Husen A, Siddiqi KS (2014) Plants and microbes assisted selenium nanoparticles: characterization and application. J Nanobiotechnol 12:28

  3. 3.

    Husen A, Siddiqi KS (2014) Carbon and fullerene nanomaterials in plant system. J Nanobiotechnol 12:16

  4. 4.

    Siddiqi KS, Husen A (2016) Fabrication of metal nanoparticles from fungi and metal salts: scope and application. Nano Res Lett 11:98

  5. 5.

    Siddiqi KS, Husen A (2016) Fabrication of metal and metal oxide nanoparticles by algae and their toxic effects. Nano Res Lett 11:363

  6. 6.

    Siddiqi KS, Husen A (2016) Engineered gold nanoparticles and plant adaptation potential. Nano Res Lett 11:400

  7. 7.

    Siddiqi KS, Husen A (2016) Green synthesis, characterization and uses of palladium/platinum nanoparticles. Nano Res Lett 11:482

  8. 8.

    Siddiqi KS, Rahman A, Tajuddin, Husen A (2016) Biogenic fabrication of iron/iron oxide nanoparticles and their application. Nano Res Lett 11:498

  9. 9.

    Siddiqi KS, Husen A (2017) Recent advances in plant-mediated engineered gold nanoparticles and their application in biological system. J Trace Elements Med Biol 40:10–23

  10. 10.

    Siddiqi KS, Husen A, Rao RAK (2018) A review on biosynthesis of silver nanoparticles and their biocidal properties. J Nanobiotechnol 16:14

  11. 11.

    Rai M, Yadav A, Gade A (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27:76–83

  12. 12.

    Sawai J (2003) Quantitative evaluation of antibacterial activities of metallic oxide powders (ZnO, MgO and CaO) by conductimetric assay. J Microbiol Methods 54:177–182

  13. 13.

    Roselli M, Finamore A, Garaguso I, Britti MS, Mengheri E (2003) Zinc oxide protects cultured enterocytes from the damage induced by Escherichia coli. J Nutr 133:4077–4082

  14. 14.

    Husen A (2017) Gold nanoparticles from plant system: Synthesis, characterization and their application, In: Nanoscience and Plant–Soil Systems Vol.–48 (Eds. Ghorbanpourn M, Manika K, Varma A) Springer International Publishing AG, Gewerbestrasse 11, 6330 Cham, Switzerland, pp.455–479

  15. 15.

    Chaudhry Q, Scotter M, Blackburn J, Ross B, Boxall A, Castle L, Aitken R, Watkins R (2008) Applications and implications of nanotechnologies for the food sector. Food Add Cont: Part A 25:241–258

  16. 16.

    Jansen J, Karges W, Rink L (2009) Zinc and diabetes—clinical links and molecular mechanisms. J Nutr Biochem 20:399–417

  17. 17.

    Maremanda KP, Khan S, Jena G (2014) Zinc protects cyclophosphamide-induced testicular damage in rat: involvement of metallothionein, tesmin and Nrf2. Biochem Biophys Res Commun 445:591–596

  18. 18.

    Kim MH, Seo JH, Kim HM, Jeong HJ (2014) Zinc oxide nanoparticles, a novel candidate for the treatment of allergic inflammatory diseases. Eur J Pharmacol 738:31–39

  19. 19.

    Frederickson CJ, Koh JY, Bush AI (2005) The neurobiology of zinc in health and disease. Na Rev Neurosci 6:449–462

  20. 20.

    Halioua B, Ziskind B (2005) Medicine in the days of the pharaohs. Press of Harvard University Press, Belknap

  21. 21.

    Ozgur U, Ya IA, Liu C, Teke A, Reshchikov MA, Doğan S, Avrutin V, Cho SJ, Morkoç H (2005) A comprehensive review of ZnO materials and devices. J Appl Phys 98:041301

  22. 22.

    Klingshirn C ZnO: from basics towards applications. Phys Status Solidi 244:3027–3073

  23. 23.

    De Graaf TP, Galley E, Butcher KE (1999) Use of an antimicrobial agent. European patent, p EP1079799

  24. 24.

    Brahms J, Mattai J, Jacoby R, Chopra S, Guenin E (2005) Dry deodorant containinga sesquiterpene alcohol and zinc oxide. U.S. Patent 20050191257 A1

  25. 25.

    Speight JG (2002) Chemical and process design handbook. McGraw Hill, Inc., New York

  26. 26.

    Brown HE (1976) Zinc oxide: properties and applications. International Lead Zinc Research Organization, New York

  27. 27.

    Lopes de Romana D, Brown KH, Guinard JX (2002) Sensory trial to assess the acceptability of zinc fortificants added to iron-fortified wheat products. J Food Sci 67:461–465

  28. 28.

    Szabo T, Nemeth J, Dekany I (2003) Zinc oxide nanoparticles incorporated in ultrathin layer silicate films and their photocatalytic properties. Coll Surf A 230:23–35

  29. 29.

    Auer G, Griebler WD, Jahn B (2005) Industrial inorganic pigments, 3rd edn. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim

  30. 30.

    Heideman G, Noordermeer JWM, Datta RN, Noordermeer WM, van Baarle B (2006) Various ways to reduce zinc oxide levels in S-SBR rubber compounds. Macromol Symp 245-246:657–667

  31. 31.

    Patnaik P (2003) Handbook of inorganic chemicals. McGraw Hill, New York

  32. 32.

    Araujo-Lima CF, Nunes RJM, Carpes RM, Aiub FAF, Felzenszwalb I (2017) Pharmacokinetic and toxicological evaluation of a zinc gluconate-based chemical sterilant using in vitro and in silico approaches. BioMed Res Inter 2017:5746768

  33. 33.

    Wang TX, Lou TJ (2008) Solvothermal synthesis and photoluminescence properties of ZnO nanorods and nanorod assemblies from ZnO2 nanoparticles. Mater Lett 62:2329–2331

  34. 34.

    Jang JS, Yu CJ, Choi SH, Ji SM, Kim ES, Lee JS (2008) Topotactic synthesis of mesoporous ZnS and ZnO nanoplates and their photocatalytic activity. J Catal 254:144–155

  35. 35.

    Mahmud S, Johar M, Abdullah PGA, Chong J, Mohamad AK (2006) Nanostructure of ZnO fabricated via french process and its correlation to electrical properties of semiconducting varistors. Synth React Inorg Met Org Chem Nano-Met Chem 36:155–159

  36. 36.

    Kakiuchi K, Hosono E, Kimura T, Imai H, Fujihara S (2006) Fabrication of mesoporous ZnO nanosheets from precursor templates grown in aqueous solutions. J Sol-Gel Sci Technol 39:63–72

  37. 37.

    Mahmud S, Abdullah MJ (2006) Nanotripods of zinc oxide, IEEE Conf. Emerging Technol.—Nanoelectron pp. 442–446

  38. 38.

    Shen L, Zhang H, Guo S (2009) Control on the morphologies of tetrapod ZnO nanocrystals. Mater Chem Phys 114:580–583

  39. 39.

    Ding Y, Wang ZL (2009) Structures of planar defects in ZnO nanobelts and nanowires. Micron 40:335–342

  40. 40.

    Wang ZL (2004) Nanostructures of zinc oxide. Mater Tod 7:26–33

  41. 41.

    Wang ZL (2004) Zinc oxide nanostructures: growth, properties and applications. J Phys Condens Mat 16:R829–R858

  42. 42.

    Moezzi A, Cortie M, McDonagh A (2011) Aqueous pathways for the formation of zinc oxide nanoparticles. Dalton Trans 40:4871–4878

  43. 43.

    Xie J, Li P, Li Y, Wang Y, Wei Y (2009) Morphology control of ZnO particles via aqueous solution route at low temperature. Mater Chem Phys 114:943–947

  44. 44.

    Soares NFF, Silva CAS, Santiago-Silva P, Espitia PJP, Gonçalves MPJC, Lopez MJG, Miltz J, Cerqueira MA, Vicente AA, Teixeira J, da Silva WA, Botrel DA (2009) Active and intelligent packaging for milk and milk products. In: Coimbra JSR, Teixeira JA (eds) Engineering aspects of milk and dairy products. CRC Press Taylor & Francis Group pp, New York, pp 175–199

  45. 45.

    Baum MK, Shor-Posner G, Campa A (2000) Zinc status in human immunodeficiency virus infection. J Nutr 130:1421S–1423S

  46. 46.

    Hiller JM, Perlmutter A (1971) Effect of zinc on viral-host interactions in a rainbow trout cell line, RTG-2. Water Res 5:703–710

  47. 47.

    Restuccia D, Spizzirri UG, Parisi OI, Giuseppe Cirillo G, Iemma F, Puoci F, Vinci G, Picci N (2010) New EU regulation aspects and global market of active and intelligent packaging for food industry applications. Food Control 21:1425–1435

  48. 48.

    Espitia PJP, Soares NFF, Coimbra JSR, Andrade NJ, Cruz RS, Medeiros EAA (2015) Zinc oxide nanoparticles: synthesis, antimicrobial activity and food packaging application. Food Bioprocess Technol 5:1447–1464

  49. 49.

    Hu X, Cook S, Wang P, Hwang HM (2009) In vitro evaluation of cytotoxicity of engineered metal oxide nanoparticles. Sci Total Environ 407:3070–3072

  50. 50.

    Wang C, Lu J, Zhou L, Li J, Xu J, Li W, Zhang L, Zhong X, Wang T (2016) Effects of long-term exposure to zinc oxide nanoparticles on development, zinc metabolism and biodistribution of minerals (Zn, Fe, Cu, Mn) in mice. PLoS One 11:e0164434

  51. 51.

    Li CH, Shen CC, Cheng YW, Huang SH, Wu CC, Kao CC, Liao JW, Kang JJ (2012) Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology 6:746–756

  52. 52.

    Singh A, Singh NB, Afzal S, Singh T, Hussain I (2017) Zinc oxide nanoparticles: a review of their biological synthesis, antimicrobial activity, uptake, translocation and biotransformation in plants. J Mater Sci. https://doi.org/10.1007/s10853-017-1544-1

  53. 53.

    Kelly SA, Havrilla CM, Brady TC, Abramo KH, Levin ED (1998) Oxidative stress in toxicology: established mammalian and emerging piscine model systems. Environ Health Perspect 106:375–384

  54. 54.

    Rikans LE, Hornbrook KR (1997) Lipid peroxidation, antioxidant protection and aging. Biochim Biophys Acta 1362:116–127

  55. 55.

    Zhang L, Jiang Y, Ding Y, Povey M, York D (2007) Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids). J Nanopart Res 9:479–489

  56. 56.

    Sawai J, Shoji S, Igarashi H, Hashimoto A, Kokugan T, Shimizu M, Kojima H (1998) Hydrogen peroxide as an antibacterial factor in zinc oxide powder slurry. J Ferment Bioeng 86:521–522

  57. 57.

    Lin D, Xing B (2007) Phytotoxicity of nanoparticles: inhibition of seed germination and root growth. Environ Pollut 150:243–250

  58. 58.

    Kahru A, Ivask A, Kasemets K, Pollumaa L, Kurvet I, François M, Dubourguier HC (2005) Bio-tests and biosensors in ecotoxicological risk assessment of field soils polluted with zinc, lead and cadmium. Environ Toxicol Chem 24:2973–2982

  59. 59.

    Heinlaan M, Ivask A, Blinova I, Dubourguier HC, Kahru A (2008) Toxicity of nanosized and bulk ZnO, CuO and TiO2 to bacteria Vibrio fischeri and crustaceans Daphnia magna and Thamnocephalus platyurus. Chemosphere 71:1308–1316

  60. 60.

    Elster C, Fourest E, Baudin F, Larsen K, Cusack S, Ruigrok RW (1994) A small percentage of influenza virus M1 protein contains zinc but zinc does not influence in vitro M1 RNA interaction. Gen J Virol 75:37–42

  61. 61.

    Lee SP, Xiao J, Knutson JR, Lewis MS, Han MK (1997) Zn2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro. Biochemistry 36:173–180

  62. 62.

    Adams LK, Lyon DY, Alvarez PJJ (2006) Comparative eco-toxicity of nanoscale TiO2, SiO2, and ZnO water suspensions. Water Res 40:3527–3532

  63. 63.

    Brayner R, Ferrari-Iliou R, Brivois N, Djediat S, Benedetti MF, Fiévet F (2006) Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett 6:866–870

  64. 64.

    Stoimenov PK, Klinger RL, Marchin GL, Klabunde KJ (2002) Metal oxide nanoparticles as bactericidal agents. Langmuir 18:6679–6686

  65. 65.

    Yamamoto O, Komatsu M, Sawai J, Nakagawa ZE (2004) Effect of lattice constant of zinc oxide on antibacterial characteristics. J Mater Sci Mater Med 15:847–851

  66. 66.

    Premanathan M, Karthikeyan K, Jeyasubramanian K, Manivannan G (2011) Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidation. Nanomedicine 7:184–192

  67. 67.

    Lovric J, Cho SJ, Winnik FM, Maysinger D (2005) Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem Biol 12:1227–1234

  68. 68.

    Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Wiesner MR, Nel AE (2006) Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 6:1794–1807

  69. 69.

    Long TC, Saleh N, Tilton RD, Lowry GV, Veronesi B (2006) Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ Sci Technol 40:4346–4352

  70. 70.

    Pati R, Mehta RK, Mohanty S, Padhi A, Sengupta M, Vaseeharan B, Goswami C, Sonawane A (2014) Topical application of zinc oxide nanoparticles reduces bacterial skin infection in mice and exhibits antibacterial activity by inducing oxidative stress response and cell membrane disintegration in macrophages. Nanomedicine 10:1195–1208

  71. 71.

    Siddiqi KS, Husen A (2017) Plant response to engineered metal oxide nanoparticles. Nano Res Lett 12:92

  72. 72.

    Liu Y, He L, Mustapha A, Li H, Hu ZQ, Lin M (2009) Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157:H7. J Appl Microbiol 107:1193–1201

  73. 73.

    Dutta RK, Sharma PK, Bhargave R, Kumar N, Pandey AC (2010) Differential susceptibility of Escherichia coli cells toward transition metal-doped and matrix-embedded ZnO nanoparticles. J Phys Chem B 114:5594–5599

  74. 74.

    Banoee M, Seif S, Nazari ZE, Jafari-Fesharaki P, Shahverdi HR, Moballegh A, Moghaddam KM, Shahverdi AR (2010) ZnO nanoparticles enhanced antibacterial activity of ciprofloxacin against Staphylococcus aureus and Escherichia coli. J Biomed Mater Res B 93B:557–561

  75. 75.

    Baek YW, An YJ (2011) Microbial toxicity of metal oxide nanoparticles (CuO, NiO, ZnO, and Sb2O3) to Escherichia coli, Bacillus subtilis, and Streptococcus aureus. Sci Total Environ 409:1603–1608

  76. 76.

    Karlsson HL, Toprak MS, Fadeel B (2014) Toxicity of metal and metal oxide nanoparticle. In: Nordberg GF, Fowler BA, Nordberg M (eds) Handbook on the toxicology of metals, 4th edn. Academic Press pp, London, pp 75–112

  77. 77.

    Cho WS, Duffin R, Howie SE, Scotton CJ, Wallace WA, Macnee W, Bradley M, Megson IL, Donaldson K (2011) Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part Fibre Toxicol 8:27

  78. 78.

    Tuomela S, Autio R, Buerki-Thurnherr T, Arslan O, Kunzmann A, Andersson-Willman B, Wick P, Mathur S, Scheynius A, Krug HF, Fadeel B, Lahesmaa R (2013) Gene expression profiling of immune-competent human cells exposed to engineered zinc oxide or titanium dioxide nanoparticles. PLoS One 8:e68415

  79. 79.

    Chiang HM, Xia Q, Zou X, Wang C, Wang S, Miller BJ, Howard PC, Yin JJ, Beland FA, Yu H, Fu PP (2012) Nanoscale ZnO induces cytotoxicity and DNA damage in human cell lines and rat primary neuronal cells. J Nanosci Nanotechnol 12:2126–2135

  80. 80.

    Seabra AB, Haddad P, Duran N (2013) Biogenic synthsis of nanostructured iron compound: applications and perspectives. IET Nanobiotechnol 7:90–99

  81. 81.

    Sharma V, Anderson D, Dhawan A (2012) Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2). Apoptosis 17:852–870

  82. 82.

    Azam A, Ahmed AS, Oves M, Khan MS, Habib SS, Memic A (2012) Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study. Int J Nanomedicine 7:6003–6009

  83. 83.

    Yamamoto O (2013) Influence of particle size on the antibacterial activity of zinc oxide. Int J Inorg Mater 3:643–646

  84. 84.

    Tsoli M, Kuhn H, Brandau W, Esche H, Schmid G (2005) Cellular uptake and toxicity of Au55 clusters. Small 1:841–844

  85. 85.

    Reddy KM, Feris K, Bell J, Wingett DG, Hanley C, Punnoose A (2007) Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Appl Phys Lett 90:2139021–2139023

  86. 86.

    Jeng HA, Swanson J (2006) Toxicity of metal oxide nanoparticles in mammalian cells. J Enviorn Sci Health 41:2699–2711

  87. 87.

    Nair S, Sasidharan A, Divya Rani VV, Menon D, Nair S, Manzoor K, Raina S (2009) Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. J Mater Sci Mater Med 20:S235–S241

  88. 88.

    Raghupathi KR, Koodali RT, Manna AC (2011) Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc oxide nanoparticles. Langmuir 27:4020–4028

  89. 89.

    Jones N, Ray B, Koodali RT, Manna AC (2008) Antibacterial activity of ZnO nanoparticles suspensions on a broad spectrum of microorganisms. FEMS Microbiol Lett 279:71–76

  90. 90.

    Sahu D, Kannan GM, Tailang M, Vijayaraghavan R (2016) In vitro cytotoxicity of nanoparticles: a comparison between particle size and cell type. J Nanosci 2016:4023852

  91. 91.

    Ng CT, Yong LQ, Hande MP, Ong CN, Yu LE, Bay BH, Baeg GH (2017) Zinc oxide nanoparticles exhibit cytotoxicity and genotoxicity through oxidative stress responses in human lung fibroblasts and Drosophila melanogaster. Int J Nanomedicine 12:1621–1637

  92. 92.

    Papavlassopoulos H, Mishra YK, Kaps S, Paulowicz I, Abdelaziz R, Elbahri M, Maser E, Adelung R, Röhl C (2014) Toxicity of functional nano-micro zinc oxide tetrapods: impact of cell culture conditions, cellular age and material properties. PLoS One 9:e84983

  93. 93.

    Taccola L, Raffa V, Riggio C, Vittorio O, Iorio MC, Vanacore R, Pietrabissa A, Cuschieri A (2011) Zinc oxide nanoparticles as selective killers of proliferating cells. Int J Nanomedicine 6:1129–1140

  94. 94.

    Zhou YM, Zhong CY, Kennedy IM, Leppert VJ, Pinkerton KE (2003) Oxidative stress and NFkappaB activation in the lungs of rats: a synergistic interaction between soot and iron particles. Toxicol Appl Pharmacol 190:157–169

  95. 95.

    Yang H, Liu C, Yang D, Zhang H, Xi Z (2009) Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol 29:69–78

  96. 96.

    Schwartz VB, Thétiot F, Ritz S, Pütz S, Choritz L, Lappas A, Förch R, Landfester K, Jonas U (2012) Antibacterial surface coatings from zinc oxide nanoparticles embedded in poly(N-isopropylacrylamide) hydrogel surface layers. Adv Funct Mater 22:2376–2386

  97. 97.

    Stankovic A, Dimitrijevic S, Uskokovic D (2013) Influence of size scale and morphology on antibacterial properties of ZnO powders hydrothermally synthesized using different surface stabilizing agents. Colloids Surf B 102:21–28

  98. 98.

    Laurent S, Forge D, Port M, Roch A, Robic C, Elst LV, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064–2110

  99. 99.

    Yamamoto O, Hotta M, Sawai J, Sawai J, Sasamoto T, Kojima H (1998) Influence of powder characteristic of ZnO on antibacterial activity: effect of specific surface area. J Ceram Soc Jpn 106:1007–1011

  100. 100.

    Kumar PTS, Lakshmanan VK, Anilkumar TV, Ramya C, Reshmi P, Unnikrishnan AG, Nair SV, Jayakumar R (2012) Flexible and microporous chitosan hydrogel/nano ZnO composite bandages for wound dressing: in vitro and in vivo evaluation. ACS Appl Mater Interfaces 4:2618–2629

  101. 101.

    George S, Pokhrel S, Xia T, Gilbert B, Ji Z, Schowalter M, Rosenauer A, Damoiseaux R, Bradley KA, Mädler L, Nel AE (2010) Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano 4:15–12

  102. 102.

    Song W, Zhang J, Guo J, Zhang J, Ding F, Li L, Sun Z (2010) Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles. Toxicol Lett 199:389–339

  103. 103.

    Buerki-Thurnherr T, Xiao L, Diener L, Arslan O, Hirsch C, Maeder-Althaus X, Grieder K, Wampfler B, Mathur S, Wick P, Krug HF (2013) In vitro mechanistic study towards a better understanding of ZnO nanoparticle toxicity. Nanotoxicology 7:402–416

  104. 104.

    Gilbert B, Fakra SC, Xia T, Pokhrel S, Mädler L, Nel AE (2012) The fate of ZnO nanoparticles administered to human bronchial epithelial cells. ACS Nano 6:4921–4930

  105. 105.

    Raffi M, Hussain F, Bhatti TM, Akhter JI, Hameed A, Hasan MM (2008) Antibacterial characterization of silver nanoparticles against E. Coli ATCC-15224. J Mater Sci Technol 24:2192–2196

  106. 106.

    Choi OK, Hu ZQ (2008) Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria. Environ Sci Technol 42:4583–4588

  107. 107.

    Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PK, Chiu JF, Che CM (2005) Proteomic analysis of the mode of antibacterial action of silver nanoparticles. Proteome Res 5:916–924

  108. 108.

    Pal S, Tak YK, Song JM (2007) Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 73:1712–1720

  109. 109.

    Sondi I, Salopek-Sondi B (2004) Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interf Sci 275:177–182

  110. 110.

    Elechiguerra J, Burt J, Morones J, Camacho-Bragado A, Gao X, Lara HH, Yacaman MJ (2005) Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol 3:6

  111. 111.

    Huang Z, Zheng X, Yan D, Yin G, Liao X, Kang Y, Yao Y, Huang D, Hao B (2008) Toxicological effect of ZnO nanoparticles based on bacteria. Langmuir 24:4140–4144

  112. 112.

    Zan L, Fa W, Peng T, Gong ZK (2007) Photocatalysis effect of nanometer TiO2 and TiO2-coated ceramic plate on hepatitis B virus. J Photochem Photobiol B 86:165–169

  113. 113.

    Bajpai KS, Chand N, Chaurasia V (2012) Nano zinc oxide-loaded calcium alginate films with potential antibacterial properties. Food Bioprocess Technol 5:1871–1881

  114. 114.

    Xie Y, He Y, Irwin LP, Jin T, Shi X (2011) Antibacterial activity and mechanism of action of zinc oxide nanoparticles against Campylobacter jejuni. Appl Environ Microbiol 77:2325–2331

  115. 115.

    Akbar A, Anal AK (2014) Zinc oxide nanoparticles loaded active packaging, a challenge study against Salmonella typhimurium and Staphylococcus aureus in ready-to-eat poultry meat. Food Control 38:88–95

  116. 116.

    Akhtar MJ, Ahamed M, Kumar S, Majeed Khan MA, Ahmad J, Alrokayan SA (2012) Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int J Nanomedicine 7:845–857

  117. 117.

    Leung YH, Xu X, Ma APY, Liu F, Ng AMC, Shen Z, Gethings LA, Guo MY, Djurišić AB, Lee PKH, Lee HK, Chan WK, Leung FCC (2016) Toxicity of ZnO and TiO2 to Escherichia coli cells. Sci Rep 6:35243

  118. 118.

    Sinha R, Karan R, Sinha A, Khare SK (2011) Interaction and nanotoxic effect of ZnO and Ag nanoparticles on mesophilic and halophilic bacterial cells. Bioresour Technol 102:1516–1520

  119. 119.

    Jones N, Ray B, Ranjit KT, Manna AC (2008) Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms. FEMS Microbiol Lett 279:71–76

  120. 120.

    Wahab R, Mishra A, Yun SI, Kim YS, Shin HS (2010) Antibacterial activity of ZnO nanoparticles prepared via non-hydrolytic solution route. Appl Microbiol Biotechnol 87:1917–1925

Download references

Acknowledgements

The authors are thankful to publishers for the permission to adopt the table and figures in this review.

Author information

AH, KSS, AR, and T gathered the research data. AH and KSS analyzed these data and wrote this review paper. All the authors read and approved the final manuscript.

Correspondence to Azamal Husen.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Siddiqi, K.S., ur Rahman, A., Tajuddin et al. Properties of Zinc Oxide Nanoparticles and Their Activity Against Microbes. Nanoscale Res Lett 13, 141 (2018) doi:10.1186/s11671-018-2532-3

Download citation

Keywords

  • Zinc oxide nanoparticles
  • Microorganisms
  • Antimicrobial
  • Toxicity
  • Mechanism
  • Biodistribution